MedPath
NMPA Approval

Buprenorphine Transdermal Patches

国药准字HJ20181113

November 16, 2022

H20181113

Drug Information

丁丙诺啡透皮贴剂

贴剂

20mg/贴

化学药品

November 16, 2022

November 15, 2027

Company Information

Applicant Company

Mundipharma GmbH

De Saint-Exupéry-Straβe 10, 60549 Frankfurt am Main, Germany

Manufacturing Company

Lohmannstr. 2,D–56626 Andernach,Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

丁丙诺啡透皮贴剂 - NMPA 批准文号 | MedPath